The pathophysiology of perioperative myocardial infarction: Facts and perspectives

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 17, Issue 1, 2003, Pages 90-100

  Landesberg, Giora ^a,b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Myocardial infarction; Myocardial ischemia; Noncardiac surgery; Pathophysiology; Postoperative

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL;

ANGIOCARDIOGRAPHY; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; DYSLIPOPROTEINEMIA; ELECTROCARDIOGRAM; HEART INFARCTION; HUMAN; MORTALITY; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; THROMBOCYTE AGGREGATION; VASOCONSTRICTION;

EID: 0037292937     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2003.18     Document Type: Review

References (103)

1. Mangano DT: Adverse outcomes after surgery in the year 2001 - A continuing odyssey. Anesthesiology 88:561-564, 1998
2. Poldermans D, Boersma E, Bax JJ, et al: The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 341:1789-1794, 1999
3. Mangano DT, Browner WS, Hollenberg M, et al: Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med 323:1781-1788, 1990
4. Landesberg G, Luria MH, Cotev S, et al: Importance of longduration postoperative ST-segment depression in cardiac morbidity after vascular surgery. Lancet 341:715-719, 1993
5. Landesberg G, Mosseri M, Zahger D, et al: Myocardial infarction following vascular surgery: The role of prolonged, stress-induced, ST-depression-type ischemia. J Am Coll Cardiol 37:1839-1845, 2001
6. Badner NH, Knill RL, Brown JE, et al: Myocardial infarction after noncardiac surgery. Anesthesiology 88:572-578, 1998
7. Goldman L, Adler J: General anesthesia and noncardiac surgery in patients with heart disease, in Braunwald E, Zipes DP, Libby P (eds): Heart Disease: A Textbook of Cardiovascular Medicine (ed 6). Philadelphia, PA, Saunders, 2001, pp 2084-2095
8. Tarhan S, Moffitt EA, Taylor WF, Guiliani ER: Myocardial infarction after general anesthesia. JAMA 220:1451-1454, 1972
9. Rao TL, Jacobs KH, El-Etr AA: Reinfarction following anesthesia in patients with myocardial infarction. Anesthesiology 59:499-505, 1983
10. Saphir O, Priest WS, Hamburger WW, et al: Coronary arteriosclerosis, coronary thrombosis and the resulting myocardial changes. Am Heart J 10:567, 1935
11. Mauney FM, Ebert PA, Sabiston DC: Postoperative myocardial infarction: a study of predisposing factors, diagnosis and mortality in a high-risk group of surgical patients. Ann Surg 172:497-503, 1970
12. Fuster V, Badimon L, Badimon J, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326:242-250, 310-318, 1992
13. Yeghiazarians Y, Braunstein JB, Askari A, Stone PH: Unstable angina pectoris. N Engl J Med 342:101-114, 2000
14. Muller JE, Abela GS, Nesto RW, Tofler GH: Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol 23:809-813, 1994
15. Quyyumi AA, Panza JA, Diodati JG, et al: Circadian variation in ischemic threshold: A mechanism underlying the circadian variation in ischemic events. Circulation 86:22-28, 1992
16. Bridges AB, McLaren M, Scott NA, et al: Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease. Br Heart J 69:121-124, 1993
17. Gnecchi-Ruscone T, Piccaluga E, Guzzetti S, et al. Morning and Monday: critical periods for the onset of acute myocardial infarction: The GISSI 2 Study Experience. Eur Heart J 15:882-887, 1994
18. Trichopoulos D, Katsouyanni K, Zavitsanos X, et al: Psychological stress and fatal heart attack: the Athens (1981) earthquake natural experiment. Lancet 1:441-444, 1983
19. Mittleman MA, Maclure M, Tofler GH, et al: Triggering of acute myocardial infarction by heavy physical exertion: protection against triggering by regular exertion. N Engl J Med 329:1677-1683, 1993
20. Curfman GD: Is exercise beneficial - Or hazardous - To your heart? N Engl J Med 329:1730-1731, 1993
21. Braunwald E, Zipes DP, Libby P: Heart Disease: A Textbook of Cardiovascular Medicine (ed 6). Saunders, PA, 2001, p 2105
22. Badimon JJ, Badimon L, Turitto VT, Fuster V: Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels. Atheroscleros Thromb 11:395-402, 1991
23. Fuster V, Chesebro JH, Frye RL, Elveback LR: Platelet survival and the development of coronary artery disease in the young adult: effect of cigarette smoking, strong family history and medical therapy. Circulation 63:546-551, 1981
24. Drexler H, Hornig B: Endothelial dysfunction in human disease. J Mol Cell Cardiol 31:51-60, 1999
25. Epstein FH. Plasminogen-activator inhibuitor type-and coronary artery disease. N Engl J Med 342:1792-1801, 2000
26. Oseroff A, Krishnamurti C, Hassett A, et al: Plasminogen-activator and plasminogen-activator inhibitor activities in men with coronary artery disease. J Lab Clin Med 113:88-93, 1990
27. Humphries JO, Kuller L, Ross RS, et al: Natural history of ischemic heart disease in relation to angiographic findings. Circulation 49:489, 1974
28. Proudfit WJ, Bruschke AVG, MacMillan JP, et al: Fifteen-year survival study of patients with obstructive coronary artery disease. Circulation 68:986, 1983
29. Harris PJ, Behar VS, Conley JJ, et al: The prognostic significance of 50 percent coronary stenosis in medically treated patients with coronary artery disease. Circulation 62:240, 1980
30. Emond M, Mark MB, Davis KB, et al: Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) registry. Circulation 90:2645, 1994
31. Brown G, Albers JJ, Fisher LD, et al: Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 323:1289, 1990
32. Ambrose JA, Tannenbaum MA, Alexopoulos D: Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 12:56, 1988
33. Little WC, Constantinescu M, Applegate RJ, et al: Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 78:1157, 1988
34. Fishbein MC, Siegel RJ: How big are coronary arteries that rupture? Circulation 94:2662-2666, 1996
35. Klein LW, Helfant RH: The Q-wave and non-Q wave myocardial infarction: Differences and similarities. Prog Cardiovasc Dis 29:205-220, 1986
36. Phibbs B, Marcus F, Marriott HJC, et al: Q-Wave versus non-Q wave myocardial infarction: A meaningless distinction. J Am Coll Cardiol 33:576-582, 1999
37. DeWood MA, Spores J, Notske RN, et al: Prevalence of total coronary artery occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303:897, 1980
38. Betriu A, Castaner A, Sanz GA, et al: Angiographic finding 1 month after myocardial infarction: A prospective study of 259 survivors. Circulation 65:1099, 1982
39. Keen WD, Savage MP, Fischman DL, et al: Comparison of coronary angiographic findings during the first six hours of non-Q-wave and Q-wave myocardial infarction. Am J Cardiol 74:324, 1994
40. DeWood MA, Stifter WF, Simpson CS, et al: Coronary arteriographic findings soon after non-Q wave myocardial infarction. N Engl J Med 315:417, 1986
41. Boden WE, Gibson RS, Schechtman KB, et al: ST segment shifts are poor predictors of subsequent Q wave evolution in acute myocardial infarction. A natural history study of early non-Q wave infarction. Circulation 79:537-548, 1989
42. Willich SN, Stone PH, Muller JE, et al: High-risk subgroups of patients with non-Q wave infarction based on direction and severity of ST segment deviation. Am Heart J 114:1110-1119, 1987
43. Guadangnoli E, Hauptman PJ, Ayanian JK, et al: Variation in the use of cardiac procedures after acute myocardial infarction. N Engl J Med 333:573-578, 1995
44. Gibson RS: Non-Q-wave myocardial infarction, in Fuster V, Ross R, Topol EJ (eds): Atherosclerosis and Coronary Artery Disease. Philadelphia, PA, Lippincott Raven, 1996, pp 1097-1123
45. Leibson PR, Klein L: The non-Q wave myocardial infarction revisited: 10 years later. Prog in Cardiovasc Dis 39:399-444, 1997
46. Willich SN, Stone PH, Muller JE, et al: High-risk subgroups of patients with non-Q myocardial infarction based on direction and severity of ST segment deviation. Am Heart J 114:1110-1119, 1987
47. Friefeld AG, Schuster EH, Bulkley BH, et al: Nontransmural versus transmural myocardial infarction: A morphologic study. Am J Med 75:423-432, 1983
48. Gibson RS: Non-Q wave myocardial infarction: Diagnosis, prognosis and management. Curr Probl Cardiol 13:9-72, 1988
49. The TIMI 3A Investigators: Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation 87:38-52, 1993
50. Violaris AG, Campbell S: Low-dose aspirin and heparin in unstable coronary artery disease. Lancet 337:489-490, 1991
51. Anderson HV, Cannon CP, Stone PH, et al: One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave MI. J Am Coll Cardiol 26:1643-1650, 1995
52. Braunwald E, Antman E, Beasley JW, et al: ACC/AHA Guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations. Circulation 102:1193-1209, 2000
53. Theroux P, Waters D, Qiu S, et al: Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation 88:2045-2048, 1993
54. Deedwania PC, Carbajal EV: Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation 81:748-756, 1990
55. Pepine CJ, Sharaf B, Andrews TC, et al: Relation between clinical, angiographic and ischemic findings at baseline and ischemia-related adverse outcomes at 1 year in the Asymptomatic Cardiac Ischemia Pilot study. J Am Coll Cardiol 29:1483-1489, 1997
56. Davies RF, Goldberg AD, Forman S, et al, for the ACIP Investigators: Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: Outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 95:2037-2043, 1997
57. Pepine CJ, Cohn PF, Deedwania PC, et al: Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST), Circulation 90:762-768, 1994
58. Mangano DT, Layug EL, Wallace A, Tateo I: Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335:1713-1720, 1996
59. Pepine CJ: Prognostic implications of silent myocardial ischemia. N Engl J Med 334:113-114, 1996
60. Fox KM, Mulcahy DA: Therapeutic rationale for the management of silent ischemia. Circulation 82:11155-160, 1990
61. Sharp SD, Mason JW, Bray B: Comparison of ST depression recorded by Holter monitors and 12-lead ECGs during coronary angiography and exercise testing. J Electrocardiol 25:323-331, 1992
62. Raby KE, Barry J, Treasure CB, et al: Usefulness of Holter monitoring for detecting myocardial ischemia in patients with nondiagnostic exercise treadmill test. Am J Cardiol 72:889-893, 1993
63. Adams JE 3rd, Sicard GA, Allen BT, et al: Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med 330:670-674, 1994
64. Rapp HJ, Rabethge S, Luiz T, et al: Perioperative ST-segment depression and troponin T release. Identification of patients with highest risk for myocardial damage. Acta Anaesthesiol Scand 43:124-129, 1999
65. Breslow MJ, Parker SD, Frank SM, et al: Determinants of catecholamine and cortisol responses to lower extremity revascularization. The PIRAT Study Group. Anesthesiology 79:1202-1209, 1993
66. Garcia-Dorado D, Theroux P, Elizaga J, et al: Influence of tachycardia and arterial hypertension on infarct size in the pig. Cardiovasc Res 22:620-626, 1988
67. Indolfi C, Ross J Jr: The role of heart rate in myocardial ischemia and infarction: Implications of myocardial perfusion-contraction matching. Prog Cardiovasc Dis 36:61-74, 1993
68. Canty JM, Giglia J, Kandath D: Effect of tachycardia on regional function and transmural myocardial perfusion during graded coronary pressure reduction in conscious dogs. Circulation 82:1815-1825, 1990
69. Ross J Jr: Myocardial perfusion contraction matching: implications for coronary heart disease and hibernation. Circulation 83:1076-1083, 1991
70. Shell WE, Sobel BE: Deleterious effects of increased heart rate on infarct size in the conscious dog. Am J Cardiol 31:474-479, 1973
71. Gewirtz H, Williams DO, Most AS: Recovery of myocardial function following brief versus prolonged atrial pacing stress in the presence of coronary stenosis. Cardiovasc Res 18:702-710, 1984
72. Matsuzaki M, Gallagher KP, Kemper WS, et al: Sustained regional dysfunction produced by prolonged coronary stenosis: gradual recovery after reperfusion. Circulation 68:170-182, 1989
73. Hening R, Gilpin E, Cowell JW, et al: Prognosis after acute myocardial infarction: A multivariate analysis on mortality and survival. Circulation 59:1124-1136, 1979
74. ISIS-1 (First International Study of Infarct Survival) Collaborative Group: Randomized trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction. Lancet 2:57-65, 1986
75. Cohen MC, Muller JE: Onset of acute myocardial infarction: Circadian variation and triggers. Cardiovasc Res 26:831, 1992
76. Landesberg G, Zhou W, Aversano T: Tachycardia-induced subendocardial necrosis: A noncoronary-thrombosis cause of postoperative myocardial infarction. Anesth Analg 88:973-979, 1999
77. Held PH, Yusuf S: Effects of beta-blockers and calcium channel blockers in acute myocardial infarction. Eur. Heart J 14:18, 1993
78. Pepine CJ, Cohn PF, Deedwania PC, et al: Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life: The Atenolol Silent Ischemia Study. Circulation 90:762-768, 1994
79. CIBIS-II Investigators and Committees: The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 353:9-13, 1999
80. Barron HV, Viskin S, Lundstrom RJ, et al: Beta-blocker dosage and mortality after myocardial infarction: Data from a large health maintenance organization. Arch Intern Med 158:449-453, 1998
81. Wallace A, Layug B, Tateo I, et al: Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology 88:7-17, 1998
82. Pasternack PF, Imparato AM, Baumann FG, et al: The hemodynamics of beta-blockade in patients undergoing abdominal aortic aneurysm repair. Circulation 76:1111-7, 1987
83. Stone JG, Foex P, Sear JW, et al: Risk of myocardial ischaemia during anaesthesia in treated and untreated hypertensive patients. Br J Anaesth 61:675-679, 1988
84. Mangano DT, Layug EL, Wallace A, Tateo I: Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 335:1713-1720, 1996
85. Rabkin SW, Huff MW, Newman C, et al: Lipids and lipoproteins during antihypertensive drug therapy. Comparison of doxazosin and atenolol in a randomized, double-blind trial: The Alpha Beta Canada study. Hypertension 24:241, 1994
86. Knight CJ, Panesar M, Wilson DJ, et al: Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable angina. Circulation 95:125-132, 1997
87. Feldman RD, Christy JP, Paul ST, Harrison DG: Beta-adrenergic receptors on canine coronary collateral vessels: Characterization and function. Am J Physiol 257:H1634, 1989
88. Kendall MJ, Lynch KP, Hjalmarson A: β-Blockers and sudden cardiac death. Ann Intern Med 123:358, 1995
89. The Danish Study Group on Verapamil in Myocardial Infarction: Effect of verapamil on mortality and major events after acute infarction Am J Cardiol. 66:779, 1990
90. Gibson RS, Boden WE, Theroux P, et al: Diltiazem and reinfarction in patients with non-Q wave myocardial infarction: Results of a double-blind randomized multicenter trial. N Engl J Med 315:423-429, 1986
91. Wilcox RG, Hampton JR, Banks DC, et al: Trial of early nifedipine in acute myocardial infarction: The TRENT stud. BMJ 293:1204-1208, 1986
92. Gunderson T, Grottum P, Pedersen T, et al, for the Norwegian Multicenter Study Group: Effect of timolol on mortality and reinfarction after acute myocardial infarction: Prognostic importance of heart rate at rest. Am J Cardiol 58:20-25, 1986
93. Kjekshus JK: Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trals. Am J Cardiol 57:43F-49F, 1986
94. Calvin JE, Kieser TM, Walley VM, et al: Cardiac mortality and morbidity after vascular surgery. Can J Surg. 1986 29:93-7
95. Dawood MM, Kutpa DK, Southern J, et al: Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol 57:37-44, 1996
96. Park AE, McCarthy WJ, Pearce WH, et al: Carotid plaque morphology correlates with presenting symptomatology. J Vasc Surg 27:872-878, 1998
97. Cohen MC, Aretz TH: Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol 8:1333-1390, 1990
98. Davies MJ, Thomas AC: Plaque fissuring: The cause of acute myocardial infarction, sudden ischemic death and crescendo angina. Br Heart J 53:363, 1985
99. Green LH, Seroppian E, Handin RI: Platelet activation during exercise-induced myocardial ischemia. N Engl J Med 302:193-197, 1980
100. Rosing DR, Brakman P, Redwood DR: Blood fibrinolytic activity in man: diurnal variation and the response to varying intensities of exercise. Circ Res 27:171-184, 1970
101. Sametz W, Metzler H, Gries M, et al: Perioperative catecholamine changes in cardiac risk patients. Eur J Clin Invest 29:582-587, 1999
102. Nabel GE, Selwyn AP, Ganz P: Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate. Circulation 81:850-859, 1990
103. Sambuceti G, Marzilli M, Marraccini P, et al: Coronary vasoconstriction during myocardial ischemia induced by rises in metabolic demand in patients with coronary artery disease. Circulation 95:2652-2659, 1997